Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zachary M. Sandusky"'
Publikováno v:
STAR Protocols, Vol 2, Iss 1, Pp 100270- (2021)
Summary: A FACS protocol is described that eliminates isolation and staining artifacts to allow accurate comparison between cell populations isolated from organs obtained from disparate mouse groups. This protocol was validated by characterizing the
Externí odkaz:
https://doaj.org/article/312d549c52364b15862dbe7d55cdb96f
Autor:
Deborah A. Lannigan, George A. O'Doherty, Jennifer A. Pietenpol, David R. Brenin, Miranda E. Sowder, Lejla Pasic, Zachary M. Sandusky, Yu Li, Mingzong Li, J. Preston Campbell, Katarzyna A. Ludwik
Metastatic breast cancer is an incurable disease and identification of novel therapeutic opportunities is vital. Triple-negative breast cancer (TNBC) frequently metastasizes and high levels of activated p90RSK (RSK), a downstream MEK-ERK1/2 effector,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1112720a72a8ecae1a317a315623e14
https://doi.org/10.1158/1535-7163.c.6538488.v1
https://doi.org/10.1158/1535-7163.c.6538488.v1
Autor:
Deborah A. Lannigan, George A. O'Doherty, Jennifer A. Pietenpol, David R. Brenin, Miranda E. Sowder, Lejla Pasic, Zachary M. Sandusky, Yu Li, Mingzong Li, J. Preston Campbell, Katarzyna A. Ludwik
Scratch assay using HDQ-P1 cells. Top vehicle, bottom (1b) (50 μM) over a 10h time frame.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe2f4a87b8e3cb08826060d505d988c
https://doi.org/10.1158/1535-7163.22506756.v1
https://doi.org/10.1158/1535-7163.22506756.v1
Autor:
Deborah A. Lannigan, George A. O'Doherty, Jennifer A. Pietenpol, David R. Brenin, Miranda E. Sowder, Lejla Pasic, Zachary M. Sandusky, Yu Li, Mingzong Li, J. Preston Campbell, Katarzyna A. Ludwik
Supplementary Materials and Methods; Table S1 and Figures S1 through S5; Supplementary Movies S1 through S3 Legends - Supplementary Materials and Methods: Description of velocity determination, conditions for immunostaining and sources and applicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a5c0ea993aa1da9ce24a7474708a263
https://doi.org/10.1158/1535-7163.22506765
https://doi.org/10.1158/1535-7163.22506765
Publikováno v:
Hematology/oncology clinics of North America. 37(1)
The estrogen receptor is a key driver of estrogen receptor-positive breast cancers. Accumulating evidence indicates that the ESR1 ligand-binding domain mutations have an important role in acquired endocrine resistance, mainly to treatment with aromat
Autor:
Yu Li, Rajender Vemula, Qi Zhang, Shinji Fukuda, George A. O'Doherty, Bulan Wu, Zachary M. Sandusky, Deborah A. Lannigan, Mingzong Li
Publikováno v:
Organic Letters. 22:1448-1452
An asymmetric synthesis of two analogues of SL0101 (1) has been achieved. The effort is aimed at the discovery of inhibitors of the p90 ribosomal S6 kinase (RSK) with improved bioavailability. The route relies upon the use of the Taylor catalyst to r
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878:188830
Estrogen receptor-positive breast cancer is the most common type of both early and advanced breast cancer. Estrogen receptor alpha (ER) is a nuclear hormone receptor and a key driver of tumorigenesis and tumor progression in these breast cancers. As
Publikováno v:
STAR Protocols, Vol 2, Iss 1, Pp 100270-(2021)
STAR Protocols
STAR Protocols
Summary A FACS protocol is described that eliminates isolation and staining artifacts to allow accurate comparison between cell populations isolated from organs obtained from disparate mouse groups. This protocol was validated by characterizing the e
Autor:
Zachary M. Sandusky
Publikováno v:
Journal of the Endocrine Society
In response to estrogens, estrogen receptor alpha (ERα) is degraded by the 26S proteasome; however, despite the continued presence of estrogen prior to menopause, ERα protein levels are maintained by an unidentified mechanism. We find that the Ser/
Autor:
Zachary M. Sandusky, Jennifer A. Pietenpol, Deborah A. Lannigan, J. Preston Campbell, David R. Brenin, Katarzyna A. Ludwik, Mingzong Li, Yu Li, George A. O'Doherty, Lejla Pasic, Miranda E. Sowder
Publikováno v:
Molecular Cancer Therapeutics. 15:2598-2608
Metastatic breast cancer is an incurable disease and identification of novel therapeutic opportunities is vital. Triple-negative breast cancer (TNBC) frequently metastasizes and high levels of activated p90RSK (RSK), a downstream MEK-ERK1/2 effector,